Sijana H. Dzinic

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

Jun Ma, Xinan Qiao, Tristan Knight et al. · Clinical Cancer Research · 2019 · 172 citations · Full text

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

Xinyu Li, Yongwei Su, Gerard J. Madlambayan et al. · Haematologica · 2019 · 65 citations · Full text

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

Daniel A Luedtke, Yongwei Su, Jun Ma et al. · Signal Transduction and Targeted Therapy · 2020 · 65 citations · Full text

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

Xinyu Li, Yongwei Su, Katie Hege et al. · Haematologica · 2020 · 52 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +16

Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation

Fangbing Liu, Hasini A. Kalpage, Deying Wang et al. · Cancers · 2020 · 43 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +16